Enovix Corp (ENVX) SEC Filings, Feb-Mar 2026

Enovix Corp Chief Legal Officer Arthi Chakravarthy reported a tax-withholding disposition of 2,221 shares of common stock on February 24, 2026, at $6.11 per share, to cover taxes on vested RSUs. Following this, she holds 404,856 shares, including unvested RSUs and performance RSUs with future release dates.

Enovix Corporation filed Amendment No. 1 to its Annual Report for the year ended December 28, 2025 to replace the consent of Deloitte & Touche LLP. The new consent now includes references to Enovix’s effective Registration Statements on Form S-3 (Nos. 333-275524, 333-273858, and 333-281260).

The amendment also files updated certifications from the principal executive officer and principal financial officer under Rules 13a-14(a) and 15d-14(a. It does not modify any financial statements or other disclosures in the original report and does not reflect events occurring after the original filing.

Enovix Corporation is a global battery company focused on designing, developing, manufacturing and commercializing advanced lithium-ion batteries using a proprietary 100% active silicon-anode architecture. Its AI-1™ platform targets smartphones, smart eyewear, defense, industrial and emerging edge-AI devices that require higher energy density in tight spaces.

The company has shifted from a broad, standard-cell strategy to deeper vertical programs with a smaller set of large OEM and ODM customers. Manufacturing has been consolidated into Fab2 in Malaysia and facilities in South Korea, supported by R&D centers in India and the U.S. A recent independent test showed the AI-1™ smartphone battery reached 935 Wh/L volumetric energy density.

Enovix highlights substantial risks: scaling a new and complex manufacturing process, achieving targeted throughput and yields, controlling raw material and production costs, and maintaining key third‑party manufacturing and supply relationships. It also notes a history of losses, a need for additional capital, customer concentration in certain sectors, global trade and geopolitical exposure, and the possibility that products under development may not reach commercial scale or expected performance.

Enovix Corporation reported strong top-line growth but continued losses, and expanded its share repurchase capacity. For full year 2025, revenue rose to $31.8 million from $23.1 million, a 38% increase, while GAAP gross margin improved to 19.2% from negative levels in 2024. Fourth quarter 2025 revenue reached $11.3 million, up from $9.7 million, with GAAP gross margin of 22.1%.

The company still posted a 2025 GAAP net loss of $156.7 million, though this narrowed from $222.2 million in 2024, and free cash flow improved to an outflow of $113.5 million from $184.8 million. Year-end cash, cash equivalents and marketable securities totaled about $621 million. Enovix’s board authorized an additional share repurchase program of up to $75 million, alongside remaining capacity of about $1.6 million under a prior plan. For first quarter 2026, the company forecasts revenue of $6.5–7.5 million and non-GAAP net loss per share of $0.14–0.18.

Enovix Corp President and CEO Rajendra K. Talluri reported a tax-related share disposition tied to restricted stock units (RSUs). On February 18, 2026, 17,650 shares of common stock were withheld at $5.95 per share to satisfy RSU tax obligations, rather than sold in the open market.

After this withholding, Talluri directly owned 2,202,787 shares, which include 1,494,734 shares issuable upon settlement of RSUs and 95,551 vested performance RSUs (PRSUs). For the PRSUs, 50% are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, each representing one share upon settlement.

Enovix Corp Chief Accounting Officer Kristina Truong reported a tax-withholding disposition of 1,116 shares of common stock at $5.92 per share tied to RSU vesting. After this transaction, she holds 191,549 shares, including 139,724 RSUs and 4,978 vested PRSUs with future release dates.

Enovix Corp former Chief Operating Officer Ajay Marathe reported a tax-withholding disposition of 7,352 shares of common stock at $5.92 per share, tied to vesting of restricted stock units. After this withholding, he directly holds 313,893 shares. A separate disclosure notes cancellation of 596,596 RSUs, including 33,170 vested performance RSUs, with half scheduled for release on March 2, 2026 and the remainder on March 1, 2027.

Enovix Corp’s Chief Accounting Officer Kristina Truong reported a small share disposition related to equity compensation. On February 10, 2026, 278 shares of common stock were withheld at $6.28 per share to cover tax obligations from vesting restricted stock units, rather than sold on the open market.

After this tax-withholding transaction, Truong beneficially owned 192,665 shares of Enovix common stock. This total includes 141,639 shares tied to unvested RSUs and 4,978 vested performance RSUs, with half of those PRSUs scheduled to be released on March 2, 2026 and the remainder on March 1, 2027.

Enovix Corporation’s Chief Legal Officer, Arthi Chakravarthy, reported a routine tax-related share withholding tied to equity compensation. On 02/08/2026, 939 shares of Enovix common stock were withheld at a price of $6.38 per share to cover tax obligations from vesting restricted stock units (RSUs).

After this transaction, Chakravarthy beneficially owns 407,077 shares, including 276,946 shares issuable upon vesting and settlement of RSUs and 20,786 vested performance RSUs (PRSUs). Half of the PRSUs are scheduled to be released on March 2, 2026, with the remaining half on March 1, 2027.